OUTLOOK THERAPEUTICS, INC. (OTLK) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2020-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2020-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2020-06-30..
Borrowing debt
Overview →Financial period ending 2020-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2020-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2020-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2020-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 422.13M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 544.92M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 30.24M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | (m) | (m) | $422.13M | $544.92M | (m) | (m) | $30.24M | (m) |
| 2019-09-30 | (m) | (m) | $1.03M | $50.28K | (m) | (m) | $17.13M | (m) |
| 2019-06-30 | (m) | (m) | $1.05M | $62.86K | (m) | (m) | $33.21M | (m) |
| 2019-03-31 | (m) | (m) | $1.05M | $75.07K | (m) | (m) | $17.17M | (m) |
| 2018-12-31 | (m) | (m) | $56.54K | $86.95K | (m) | (m) | $18.71M | (m) |
| 2018-09-30 | (m) | (m) | $66.48K | $98.49K | (m) | (m) | $22.28M | (m) |
| 2018-06-30 | (m) | (m) | $86.73K | $111.54K | (m) | (m) | $34.09M | (m) |
| 2018-03-31 | (m) | (m) | $102.91K | $127.79K | (m) | (m) | $27.79M | (m) |
| 2017-12-31 | (m) | (m) | $118.76K | $143.49K | (m) | (m) | $32.28M | (m) |
| 2017-09-30 | (m) | (m) | $52.60K | $151.11K | (m) | (m) | $20.73M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $164.95K | (m) | (m) | $17.13M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $178.32K | (m) | (m) | $17.46M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $191.24K | (m) | (m) | $20.45M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $2.23M | (m) | (m) | $23.71M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $2.92M | (m) | (m) | $35.01M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |